What Key Growth Drivers Are Shaping The Gene Panel Market Forecast Toward $4.33 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Gene Panel Market Be Worth By 2029?
In the past few years, the size of the gene panel market has expanded significantly. The market, anticipated to be worth $2.14 billion in 2024, is projected to rise to $2.47 billion in 2025, yielding a compound annual growth rate (CAGR) of 15.2%. Factors contributing to the growth during the historic period include a rise in cases of hereditary diseases, an escalating need for genetic screening, an increase in research and development activities, a higher prevalence of congenital diseases, and a surge in demand for sophisticated treatment alternatives.
In the coming years, the gene panel market is anticipated to experience swift expansion. The market is projected to balloon to a value of $4.33 billion in 2029, with a compound annual growth rate (CAGR) of 15.1%. The expansion during this forecasted period is largely attributable to a rise in chronic diseases, elevated instances of cancer, increased cognizance of genetic testing, and enhanced government efforts alongside healthcare spending. Key trends for the forecast period comprise of the evolution of gene panel technology, strategic alliances, tailored treatments, the incorporation of artificial intelligence, and the use of cutting-edge bioinformatics tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp
What Market Forces Are Contributing To The Growth Of The Gene Panel Market?
The gene panel market’s growth is anticipated to be fueled by the rising incidence of cancer. Characterized by unregulated growth and spread of abnormal cells causing damage to surrounding tissues and organs, cancer is a collection of diseases. The increase in cancer cases can be attributed to factors such as aging populations, changes in lifestyle, exposure to environmental factors, and advancements in detection and diagnostic technologies. Gene panels contribute to cancer care by facilitating extensive genetic testing to pinpoint mutations and alterations in certain genes. This information can then be used to tailor treatment plans and enhance cancer patient outcomes. For example, statistics from the World Health Organization in February 2024 reported that about 9.7 million people perished from cancer in 2022 with 20 million new cases being diagnosed. Lung cancer, the most prevalent type of cancer globally, represented 12.4% of new diagnoses with 2.5 million new cases. Hence, the escalating incidence of cancer is stimulating the expansion of the gene panel market.
Which Segments Define The Structure Of The Gene Panel Market?
The gene panelmarket covered in this report is segmented –
1) By Product And Services: Test Kits; Testing Services
2) By Technology: Amplicon-Based; Hybridization-Based; Other Technologies
3) By Design: Predesigned Gene Panel; Customized Gene Panel
4) By Application: Cancer Risk Assessment; Diagnosis Of Congenital Diseases; Pharmacogenetics; Other Applications
5) By End-User: Research Institutes; Hospital; Diagnosis Centers; Pharmaceutical Companies; Other End-Users
Subsegments:
1) By Test Kits: Predesigned Gene Panels; Customized Gene Panels
2) By Testing Services: Cancer Risk Assessment Panels; Pharmacogenetic Testing Panels; Neurological Disorder Panels; Cardiovascular Disease Panels; Rare Disease Panels
What Strategic Shifts And Innovations Are Influencing The Gene Panel Market?
Key players in the gene panel market are advancing technology by introducing specialized tools like oncology panels to boost diagnostic accuracy, efficiency, and personalization in cancer treatment. Oncology panels are tailored genetic tests that evaluate multiple cancer-related genes to detect mutations for diagnosis, prognosis, and treatment planning. For instance, in May 2023, Vizgen Inc., a U.S.-based biotech firm, launched the MERFISH PanCancer Pathways Panel—an adaptable solution for spatial genomics research. These panels, optimized for error resilience, offer consistent, reproducible results and are particularly useful in cancer research. They integrate spatial and genetic data to provide insights into tumor environments and cellular interactions, facilitating targeted therapeutic development and advancing spatial biology.
Which Firms Are Making The Biggest Impact In The Gene Panel Market?
Major companies operating in the gene panel market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Intermountain Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., OPKO Health Inc., Myriad Genetics Inc., Guardant Health Inc., Invitae Corp., Integrated DNA Technologies Inc., Bio-Rad Laboratories Inc., Novogene Corporation, Fulgent Genetics Inc., MedGenome Inc., OriGene Technologies Inc., Centogene AG, Blueprint Genetics Inc., BIONEER Corporation, BGI Group Ltd., Vizgen Inc., Primbio Research Institute LLC
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report
Which Region Is Forecasted To Lead The Gene Panel Market In The Coming Years?
North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp
Browse Through More Reports Similar to the Global Gene Panel Market 2025, By The Business Research Company
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Prenatal And Newborn Genetic Testing Global Market Report 2025
Direct To Consumer Dtc Genetic Testing Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
